tiprankstipranks
Advertisement
Advertisement

AVTX Stock Latest News

Avalo Therapeutics initiated with an Outperform at Wolfe Research
The FlyAvalo Therapeutics initiated with an Outperform at Wolfe Research
18d ago
AVTX
Avalo Therapeutics initiated with an Outperform at Citizens
PremiumThe Fly
Avalo Therapeutics initiated with an Outperform at Citizens
20d ago
AVTX
Avalo Therapeutics price target raised to $40 from $25 at H.C. Wainwright
PremiumThe Fly
Avalo Therapeutics price target raised to $40 from $25 at H.C. Wainwright
1M ago
AVTX
AVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
AVTX
Avalo Therapeutics: Attractive Risk‑Reward in Hidradenitis Suppurativa Driven by Abdakibart’s Differentiated IL‑1β Profile and Upcoming Phase 2 LOTUS Readout
PremiumRatings
Avalo Therapeutics: Attractive Risk‑Reward in Hidradenitis Suppurativa Driven by Abdakibart’s Differentiated IL‑1β Profile and Upcoming Phase 2 LOTUS Readout
1M ago
AVTX
Psychedelic: Clearmind reports additional CMND-100 safety results
PremiumThe FlyPsychedelic: Clearmind reports additional CMND-100 safety results
2M ago
PBM
AVTX
Guggenheim starts Avalo at Buy on hidradenitis suppurativa potential
Premium
The Fly
Guggenheim starts Avalo at Buy on hidradenitis suppurativa potential
3M ago
ABBV
AVTX
Avalo Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
Avalo Therapeutics initiated with a Buy at Guggenheim
3M ago
AVTX
Avalo Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Avalo Therapeutics management to meet with Piper Sandler
3M ago
AVTX
Avalo Therapeutics management to meet with Cantor Fitzgerald
PremiumThe Fly
Avalo Therapeutics management to meet with Cantor Fitzgerald
3M ago
AVTX
De-Risked LOTUS Phase 2 Design and Monthly Dosing Support Reiterated Buy on Avalo Therapeutics
PremiumRatings
De-Risked LOTUS Phase 2 Design and Monthly Dosing Support Reiterated Buy on Avalo Therapeutics
3M ago
AVTX
Avalo Therapeutics Highlights AVTX-009 Progress in HS
PremiumCompany Announcements
Avalo Therapeutics Highlights AVTX-009 Progress in HS
3M ago
8K
AVTX
Avalo Therapeutics files $750M mixed securities shelf
PremiumThe FlyAvalo Therapeutics files $750M mixed securities shelf
4M ago
AVTX
Avalo Therapeutics initiated with an Outperform at Mizuho
Premium
The Fly
Avalo Therapeutics initiated with an Outperform at Mizuho
4M ago
AVTX
Avalo Completes Enrollment for Phase 2 LOTUS Trial
Premium
Company Announcements
Avalo Completes Enrollment for Phase 2 LOTUS Trial
5M ago
8K
AVTX
Avalo Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Avalo Therapeutics Reports Q3 2025 Financial Results
6M ago
AVTX
Avalo Therapeutics reports Q3 EPS ($2.19), consensus ($1.64)
PremiumThe Fly
Avalo Therapeutics reports Q3 EPS ($2.19), consensus ($1.64)
6M ago
AVTX
Avalo Completes Enrollment for Phase 2 LOTUS Trial
PremiumCompany Announcements
Avalo Completes Enrollment for Phase 2 LOTUS Trial
6M ago
8K
AVTX
Avalo Therapeutics completes enrollment in Phase 2 LOTUS trial
PremiumThe Fly
Avalo Therapeutics completes enrollment in Phase 2 LOTUS trial
6M ago
AVTX
Avalo Therapeutics Advances in Hidradenitis Suppurativa Treatment with AVTX-009 Study
PremiumCompany AnnouncementsAvalo Therapeutics Advances in Hidradenitis Suppurativa Treatment with AVTX-009 Study
6M ago
AVTX
Oppenheimer healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Oppenheimer healthcare analysts hold an analyst/industry conference call
6M ago
AVTX
Avalo Therapeutics management to meet with Piper Sandler
Premium
The Fly
Avalo Therapeutics management to meet with Piper Sandler
6M ago
AVTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >